PharmaCielo (TSXV:PCLO) Other Stockholders Equity : C$2.10 Mil (As of Sep. 2024)

View and export this data going back to 2018. Start your Free Trial

What is PharmaCielo Other Stockholders Equity?

PharmaCielo's Other Stockholders Equity for the quarter that ended in Sep. 2024 was C$2.10 Mil.

PharmaCielo's quarterly Other Stockholders Equity increased from Mar. 2024 (C$1.02 Mil) to Jun. 2024 (C$1.35 Mil) and increased from Jun. 2024 (C$1.35 Mil) to Sep. 2024 (C$2.10 Mil).

PharmaCielo's annual Other Stockholders Equity declined from Dec. 2021 (C$1.96 Mil) to Dec. 2022 (C$0.56 Mil) but then increased from Dec. 2022 (C$0.56 Mil) to Dec. 2023 (C$0.79 Mil).

PharmaCielo Other Stockholders Equity Historical Data

The historical data trend for PharmaCielo's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaCielo Other Stockholders Equity Chart

PharmaCielo Annual Data

Trend

Aug17

Aug18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

0.56

1.96

0.56

0.79

PharmaCielo Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Other Stockholders Equity	Get a 7-Day Free Trial															0.79	0.79	1.02	1.35	2.10

PharmaCielo Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

PharmaCielo Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of PharmaCielo's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaCielo Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaCielo Ltd (TSXV:PCLO) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

PCLOF:USA

Address

82 Richmond Street East, Toronto, ON, CAN, M5C 1P1

Website

https://www.pharmacielo.com

PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. It is licensed to produce both CBD-dominant and THC-dominant cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico. It generates the majority of its revenue in the form of the Sale of Cannabis derivative products in Colombia.

Executives

Ian D Atacan	Director, Senior Officer
Marc Lustig	Director
William Boris Petron	Director
Henning Von Koss	Director, Senior Officer
Anthony Wile	10% Security Holder